Turnaround Time

Aviation Week's Aftermarket Blog
See All Posts
  • Talk About Showing Cause...
    Posted by Sean Broderick 2:55 PM on Mar 09, 2011

    Well, that was fast.

    It's safe to say that FAA won’t be offering any flimsy show-cause explanation as to why it didn’t conduct a final regulatory flexibility analysis on its drug and alcohol rule. The agency went one better—providing said analysis in a Federal Register notice published Tuesday.

    Using ARSA survey data to help set a baseline, FAA determined that companies with at least 25 employees and $750,000-$2 million in revenue would pay about $13,000 if they had to comply by the rule.  Continued the agency:

    The FAA is aware that a substantial number of small entities must  comply with this rule; however, the percentage of cost to revenue is  less that 1 percent, therefore we believe that this rule does not have a significant economic impact. Therefore the FAA preliminarily certifies that this rule will not have a significant economic impact on a substantial number of small entities.

    ARSA acknowledged the filing and said in a release issued late Tuesday that it will "issue a robust and detailed response once we have processed the information."

    Tags: om99, ARSA, FAA

  • Recommend
  • Report Abuse

Comments on Blog Post